The Peptide Report
A growing cohort of Silicon Valley founders and operators are quietly retiring melatonin in favor of delta-sleep-inducing peptide nasal sprays. Here's the science behind the shift — and why next-day cognition is the new sleep metric.
A new category of intranasal wellness sprays is quietly reshaping how high-performers wind down at night. Inside the rise of DSIP nasal sprays among executives who refuse to trade tomorrow for tonight.
A growing wave of founders, operators, and senior leaders are quietly walking away from prescription sleep aids in favor of cleaner, doctor-formulated stacks. Here's what's driving the shift — and what the research says about the ingredients leading it.
A new generation of high-performance operators is abandoning melatonin for something more precise. Inside the quiet rise of DSIP nasal spray and the science of sleep architecture optimization.
A quiet rebellion against melatonin is reshaping how Silicon Valley sleeps. Inside the rise of DSIP nasal spray and the science of restorative rest without next-day grogginess.
A quiet shift is underway in C-suite wellness circles: high performers are abandoning single-ingredient melatonin for multi-pathway sleep stacks. Here's what the science says — and why one doctor-formulated formula is leading the conversation.
